Meprol en es it fr

Meprol Brand names, Meprol Analogs

Meprol Brand Names Mixture

  • No information avaliable

Meprol Chemical_Formula

C20H23NS

Meprol RX_link

No information avaliable

Meprol fda sheet

Meprol msds (material safety sheet)

Meprol Synthesis Reference

No information avaliable

Meprol Molecular Weight

309.469 g/mol

Meprol Melting Point

< 25 oC

Meprol H2O Solubility

Soluble as HCl salt

Meprol State

Liquid

Meprol LogP

5.7

Meprol Dosage Forms

Tablets (oral, 1 mg)

Meprol Indication

Used for the symptomatic treatment of parkinsonism.

Meprol Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meprol Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meprol side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meprol Patient Information

Meprol Organisms Affected

Humans and other mammals